|
STAU2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.91620000000015E-05 |
| Normal-vs-Stage3 |
1.62914126633495E-12 |
| Normal-vs-Stage4 |
5.64825963778048E-12 |
| Stage1-vs-Stage2 |
3.258200E-01 |
| Stage1-vs-Stage3 |
2.049800E-01 |
| Stage1-vs-Stage4 |
5.809200E-01 |
| Stage2-vs-Stage3 |
9.748200E-02 |
| Stage2-vs-Stage4 |
2.180600E-01 |
| Stage3-vs-Stage4 |
6.161400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.65201186064223E-12 |
| Normal-vs-Asian |
1.661080E-03 |
| Caucasian-vs-AfricanAmerican |
3.747200E-01 |
| Caucasian-vs-Asian |
6.590200E-01 |
| AfricanAmerican-vs-Asian |
3.864200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.12085904394144E-12 |
| Male-vs-Female |
9.261000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.84119452596133E-11 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.49500001267455E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.335200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.601400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.693800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.626600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.333800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.098000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.923300E-03 |
| Normal-vs-Grade 2 |
1.64679381242649E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
5.55111512312578E-16 |
| Grade 1-vs-Grade 2 |
3.505600E-01 |
| Grade 1-vs-Grade 3 |
5.035900E-02 |
| Grade 1-vs-Grade 4 |
2.254400E-02 |
| Grade 2-vs-Grade 3 |
4.300300E-02 |
| Grade 2-vs-Grade 4 |
1.265510E-02 |
| Grade 3-vs-Grade 4 |
1.795800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62558855265615E-12 |
| Normal-vs-ccB subtype |
1.62936331093988E-12 |
| ccA subtype-vs-ccB subtype |
4.737200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.32116539930394E-14 |
| Normal-vs-N1 |
1.97229999998605E-07 |
| N0-vs-N1 |
5.257000E-01 |
|
|
